Letter regarding, "Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses"

J Cancer Res Clin Oncol. 2021 Jul;147(7):2171-2173. doi: 10.1007/s00432-020-03508-z. Epub 2021 Jan 12.

Authors

Aayah Nounu¹, Venexia Walker², Rebecca C Richmond²

Affiliations

¹ Medical Research Council (MRC) Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK. an0435@bristol.ac.uk.
² Medical Research Council (MRC) Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.

PMID: 33433658
DOI: 10.1007/s00432-020-03508-z

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspirin / adverse effects
Genome-Wide Association Study
Humans
Lung Neoplasms* / drug therapy
Lung Neoplasms* / epidemiology
Lung Neoplasms* / genetics
Mendelian Randomization Analysis*

Substances

Aspirin

Grants and funding